Healthcare
Live Price
Offline$3.23
+3.86% today
1Y Change
-31.88%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Recursion Pharmaceuticals, Inc. (RXRX) is a Healthcare stock with a market cap of $1.57B and listed on NASDAQ. The stock last traded around $3.23 and down 31.9% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +26.9%, EPS growth of +14.8%, a dividend yield of 0.0%. What stands out right now is revenue +26.9%, EPS +14.8%, free cash flow -1.5% with operating margin -869.3% and ROIC -48.1%. Valuation already assumes a fairly strong business story at price/sales 21.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RXRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RXRX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RXRX Max Drawdown
-58.17%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RXRX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.